Grayanotoxins are known to occur in the honey produced from the nectar of Rhododendron ponticum growing on the mountains of the eastern Black Sea region of Turkey and also in Japan, Nepal, Brazil, and some parts of North America and Europe. Two cases of honey intoxication are presented here. Both of the patients experienced severe bradycardia and hypotension after ingestion of honey which was brought from Trabzon, Turkey. Microscopical examination showed Rhododendron ponticum pollen tetrades. Anesthetized albino rats were injected intraperitoneally with toxic honey extract doses equivalent to 1 or 5 g honey/kg. Dose-dependent hypotension, bradycardia and respiratory rate depression were observed. When marked bradycardia (approximately 75% of control value) was reached, rats were given atropine sulfate (2 mg/kg, i.p.) or AF-DX 116 (20 mg/kg, i.p.). Atropine sulfate improved both bradycardia and respiratory rate depression. AF-DX 116, which is a selective M 2 -muscarinic receptor antagonist, restored only heart rate, but not the respiratory rate depression. These results suggest that M 2 -muscarinic receptors are involved in cardiotoxicity of grayanotoxin.
INTRODUCTION
Grayanotoxins occur in various plants, notably Rhododendrons, Pieris and Kalmia of the botanical family Ericaceae. These toxic compounds can be found in the leaves, twigs, pollen grains and honey derived from these plants /I/. Rhododendrons grow extensively on the mountains of the eastern Black Sea area of Turkey, and are also found in Japan, Nepal, Brazil and some parts of North America and Europe /2-5/. Ingestion of "mad honey" produced from the nectar of Rhododendrons causes several symptoms, such as bradycardia, other cardiac arrhythmias, hypotension, vomiting, sweating, weakness, blurred vision, respiratory depression, mild paralysis, and convulsions /6-10/. The intoxication is rarely fatal and generally lasts for no more than 24 hours. The grayanotoxin I, also known as andromedotoxin, acetylandromedol and rhodotoxin, is usually responsible for these symptoms /5,12-14/. Administration of parenteral fluid and atropine usually restores the hypotension and bradycardia /6-11/.
Although cardiac toxicity of mad honey in man has been reported since 401 BC /5/, there is very little information on the toxic effects of mad honey extracts in experimental animals. In the present study, two cases of mad honey intoxication in man are presented and the effects of mad honey extracts on heart rate, blood pressure and respiratory rate were investigated in rats. Additionally, the effects of atropine, a nonselective antimuscarinic agent, and AF-DX 116, a selective M 2 -muscarinic receptor antagonist, were investigated on cardiac and respiratory toxicities of mad honey extract in rats.
MATERIALS AND METHODS

1) Case reports
The first patient was a 48-year-old man who complained of weakness, dizziness and faintness an hour after ingestion of 2 tablespoons of honey which had been brought from Trabzon, Turkey. He had eaten smaller amounts of the same honey previously without any adverse effects. Shortly after the onset of the symptoms he was admitted to the Marmara University Hospital with a blood pressure of 60/20 mm Hg and a pulse of 34/min-regular. He did not experience nausea, vomiting, sweating or syncope and had no history of cardiovascular disease. In the past, he had been hospitalized because of schizophrenia in 1970 and 1973. For the last 5 months, he was on salazopyrine 500 mg t.i.d. because of a probable diagnosis of inflammatory bowel disease. On physical examination, besides bradycardia and hypotension, the rest of the findings were within normal limits. The routine laboratory blood and urine tests including a chest x-ray were normal. The ECG showed sinus bradycardia (25 bpm) and occasional AV nodal escape beats.
The second patient was a 74-year-old man with chronic obstructive lung disease of long duration. He also developed weakness, dizziness, faintness and sweating half an hour after ingestion of some honey which had been brought to him from Trabzon, Turkey. He did not complain of nausea, vomiting or syncope and was admitted to the Marmara University Hospital with blood pressure of 60/30 mm Hg and pulse of 35/minirregular. His past medical history revealed a chronic lung disease without any cardiac complaints. On physical examination, in addition to bradycardia and hypotension he had a barrel chest with sibilant ronchi and coarse rales. The rest of the findings were within normal limits. The routine laboratory blood and urine tests were within normal limits while a chest x-ray revealed mild cardiomegaly, signs of emphysema and reticulonodular opacities over the lung areas. The ECG showed sinus bradycardia (37 bpm), second degree AV block (Mobitz Type I) and incomplete right bundle branch block.
Both patients responded dramatically to i.v. saline infusion containing atropine (1-2 mg). Following atropine administration, heart rate rose to tachycardic levels (sinus rhythm) and blood pressure normalized within several minutes. During the course of the first patient it was necessary to administer 0.5 mg atropine every 3 to 4 hours for 18 hours. The second patient was given only i.v. saline infusion after the initial atropine administration. Both of the patients had a normal heart rate, rhythm and blood pressure within 24 hours of the mad honey poisoning.
2) Extraction of honey
Toxic honey used in this study was supplied by the first patient presented above, who experienced severe bradycardia and hypotension after ingestion of 2 tablespoons of this honey which was brought to him from Trabzon, Turkey. On microscopic examination of the honey, Rhododendron ponticum I pollens were seen. Samples of honey were extracted according to the method described by Scott et al. /15/. Briefly, 50 g of honey was shaken with 100 ml methanol-water (1:3 v/v) until homogeneous. The mixture was adjusted to pH 6.5 with dilute NaOH (0.1 N) solution and then filtered through Whatman no. 46 filter paper. The solution was extracted 5 times with 150 ml aliquots of chloroform. The combined chloroform extracts were evaporated to near dryness on a steam bath which was maintained at 50 °C. The residue was dissolved in 5 ml of distilled water.
3) Animal experiments
Albino rats of both sexes weighing 200-250 g were used. Rats were injected intraperitoneally with equal volumes of honey extract (0.1ml/ 100g). Appropriate dilutions were made in order to give doses of extract equivalent to 1 or 5 g honey/kg to two groups of animals (n=17 and 15 respectively). Rats (n=5) injected with nontoxic honey extracts were used as a control group.
Rats were anesthetized by urethane (1.6 g/kg, i.p.). Respiratory rates were counted, and heart rates and rhythms were monitored by ECG (Nihon Kohden). In another group, direct blood pressure recordings were taken on a polygraph (Nihon Kohden, Model RM 6100) through a carotid artery cannulation and a pressure transducer. Following at least two control recordings, equal volumes of toxic or nontoxic honey extracts were injected intraperitoneally. The animals were observed for two hours after the injection.
In the group of rats injected with toxic honey extract equivalent to 1 g/kg honey, when marked bradycardia (approximately 75% of control value) was reached, saline (0.1 ml/100 g) (n=7), atropine sulfate (2 mg/kg) (n=7) or AF-DX 116 (20 mg/kg) (n=7) was injected intraperitoneally. The animals were observed for two hours after the injection of the antimuscarinic agent.
The administered drugs were as follows:
The obtained results are presented as mean ± SEM. Statistical analysis was carried out by Student's paired t-test.
RESULTS
Animal experiments
The mean heart and respiratory rates of all rats used in this study were 403.9±11.6 bpm and 99.7±2.1/min, respectively. The intraperitoneal injection of nontoxic honey extracts did not alter the heart rate, respiratory rate and mean arterial pressure (MAP) throughout the observation period. The intraperitoneal administration of toxic honey extracts reduced heart rate, respiratory rate and MAP dose-dependently (Fig-1) .
The respiratory depressant effect of toxic honey extract equivalent to 1 g/kg honey became significant 15 min after injection and respiratory rate fell to 59.1±6.2% of its control value at 90 min, while following the dose equivalent to 5 g/kg honey the change in respiratory rate was significant at 15 min and reached 12.9±2.2% of its initial value at 30 min ( Fig. 1) . The bradycardic effect of toxic honey extracts became significant after 15 min of their administration and following the dose equivalent to 1 g/kg honey, made a plateau at the level of about 75 % of their control heart rate value until the end of the observation period, while following the dose equivalent to 5 g/kg honey the heart rate reached 53.5 ±7.6% of its initial value after 90 min (Fig. 1) .
The hypotensive effect of the smaller dose of toxic honey extract became significant after 60 min of its i.p. administration and reached its maximum effect (65.2±10.4% of the initial value) after 90 min. The higher dose caused more prominent hypotension which started immediately and reached its maximum (47.8±12.2% of the initial value) after 60 min (Fig-1) .
All effects of toxic honey extract lasted until the end of the 2 h observation period. The ECG monitoring revealed AV junctional escape rhythms in 4 animals, AV block of 2 and 3 degrees in one animal, and occasional ventricular premature beats in another rat.
In animals injected with toxic honey extract equivalent to 1 g/kg honey, when the heart rate fell to approximately 75% of the control value, saline, atropine sulfate or AF-DX 116 was administered i.p. At that time mean respiratory rate was 53.0±5.5% of its control value. Atropine sulfate (2 mg/kg, i.p.) restored both bradycardia and respiratory rate depression (Fig.  2) . At the end of the observation period heart rate was restored to 88.0±4.9%, and respiratory rate to 84.3 ±5.4% of their control values. On the other hand, AF-DX 116 (20 mg/kg, i.p.) restored heart rate to 91.0±5.6% of its control level after 120 min, but did not have any effect on the respiratory rate depression induced by the mad honey extract (Fig. 2) . Effect of intraperitoneal injection at 0 time of toxic honey extract equivalent to 1 g/kg CO-O) and 5 g/kg (·-·) honey on respiratory rate, heart rate and blood pressure in rats. * significantly different from control value (p<0.05). The grayanotoxins are responsible for mad honey intoxication. In particular, grayanotoxin I is found in honey produced from the nectar of various genera of Ericaceae, notably Rhododendron, Pieris and Kalmia /l,5,11-13/.
Grayanotoxin poisoning in man may result from ingestion of the leaves, flowers /16/ and nectar /17/ of Rhododendrons, Pieris and Kalmia of the botanical family Ericacea, or use of the leaves of these plants to make tea or cigarettes for the relief of arthritis /18/, but most commonly from ingestion of grayanotoxin-contaminated honey /5/.
Although the risk of intoxication with grayanotoxin-containing honey occurs mainly in areas with Ericaceae-dominated vegetation, namely Turkey, Japan, Brazil, parts of North America, Nepal, British Columbia and parts of Europe /5,6/, nowadays the increase in travel and trade throughout the world leads to the occurrence of poisoning outside these areas. Some may be ascribed to a search for exotic tastes that can be accomplished with imported honey. Others may result from the ingestion of unprocessed honey in the quest for natural foods.
All cases previously reported share the major symptoms and signs presented in this paper, namely severe bradycardia and hypotension /6-9/. Common complaints were dizziness, weakness, excessive sweating, nausea and vomiting. Syncope and several types of cardiac dysrhythmias were observed occasionally. In severe intoxication, loss of coordination and progressive muscular weakness may develop. Convulsions are reported occasionally. In man, the symptoms of poisoning occur after a latent period of a few minutes to a few hours. The intoxication is rarely fatal. Since grayanotoxins undergo rapid metabolism and excretion /19/, spontaneous recovery is expected within 24 höurs. Administration of parenteral fluid and atropine usually restores hypotension and bradycardia.
In the present study, the toxic honey sample was extracted to isolate grayanotoxins /15/. The three major toxic effects in rats were respiratory depression, hypotension and sinus bradycardia. Bradycardia and hypotension are also characteristic effects of grayanotoxins in man. Interestingly, respiratory depression in rats was severe and respiratory rate fell to 5-10/min in most of the animals injected with 5 g/kg of toxic honey extract. In man, respiratory depression due to grayanotoxins occurs only rarely. This may depend on the amount ingested or species difference. Similar toxic effects were reported in dogs /12/, mice /15/ and guinea-pigs /6-8/, with severe respiratory depression.
Administration of parenteral fluid and atropine was usually found to be effective in restoring hypotension and bradycardia in man /5,6,8-11/. However, Gossinger et al. Π/ have reported that atropine (0.5 mg, i.v.) had not restored bradycardia, multiple atrial premature beats and conduction disturbances in their case and they have concluded that vagal stimulation does not play an important role in the origin of the cardiac conduction disturbances. Since other investigators have all reported the opposite, both in man and experimental animals, it seems likely that the atropine dose administered by Gossinger et al. ΠI was not sufficient. In our cases we treated our patients effectively with 1-2 mg atropine (i.v.). In our experiments, atropine (2 mg/kg, i.p.) restored both bradycardia and respiratory rate depression due to toxic honey extract in rats. Additionally, in guinea-pigs /6/ and dogs /12/, bilateral vagotomy was reported to prevent the grayanotoxin-induced bradycardia, but not the respiratory depression. It may be assumed that the cardiotoxic effect of grayanotoxin is mediated by n. vagus.
The muscarinic receptors of the heart which mediate the vagal effects are of the M^-subtype. AF-DX 116 used in this study is a new antibradycardic agent which selectively antagonizes iVL-muscarinic receptor-mediated responses. AF-DX 116 restored bradycardia effectively, without any effect on respiratory rate depression. It may be assumed that M^ muscarinic receptor subtypes are involved in grayanotoxin-induced cardiotoxicity, but not respiratory toxicity.
In some in vitro studies, a positive inotropic effect of grayanotoxin has been demonstrated /6,20/. Moran et al. suggested that grayanotoxins may cause both vagal stimulation and blockade of the carotid sinus pressure reflex /21/. Additionally, it was reported that grayanotoxin I increases membrane permeability to Na + in Na + -dependent excitable membranes and maintains those cells in a state of depolarization /22,24/. All the observed responses of skeletal and myocardial muscles, nerves, and the central nervous system were believed to be related to this mechanism of action /5/.
In conclusion, grayanotoxins cause severe bradycardia and hypotension in humans and, additionally, severe respiratory rate depression in rats, as has been shown also in mice, guineapigs and dogs. Grayanotoxin-induced bradycardia and hypotension can be treated by atropine. M 2 -muscarinic receptors are shown to be involved in cardiotoxicity of grayanotoxins. Since respiratory rate depression is not a prominent manifestation of grayanotoxincontaminated honey intoxication in man, AF-DX 116, which is a selective ^-muscarinic antagonist with fewer side effects than atropine, may be useful in the treatment of bradycardia and other types of arrhythmias in these patients.
